A Study of LY3867070 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

196

Participants

Timeline

Start Date

May 27, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

Healthy

Interventions

DRUG

LY3867070

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (2)

RECRUITING

Fortrea Clinical Research Unit, Dallas

NOT_YET_RECRUITING

Anaheim Clinical Trials, LLC, Anaheim

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY